Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning

Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning

The effects and safety of Human cord blood mononuclear cell for delayed encephalopathy after carbon monoxide poisoning

To evaluate the effect and mechanism of human cord blood mononuclear cell transplantation for delayed encephalopathy after carbon monoxide poisoning

Inclusion Criteria:

• 35-60 years old.
• No serious infection, chronic diseases, diabetes and tuberculosis.
• Written informed consents were obtained from all subjects.
• Symptomatic Delayed Encephalopathy After Carbon Monoxide Poisoning.

Exclusion Criteria:

• The heart, liver, kidney and other viscera serious organic disease.
• Allergic constitution, clotting disorders, autoimmune diseases and tumors.
• Pregnancy.
• Moribund patient.
• History of prior brain injury.
• History of central nervous system disease.